Cannabis sativa Extract Reduces Cytoskeletal Associated Proteins in Breast Cancer Cell Line

Authors Information
Article Notes and Dates
To Cite : Dana N, Tajaddini M H, Haghjooy Javanmard S, Jafari E, Abed A, et al. Cannabis sativa Extract Reduces Cytoskeletal Associated Proteins in Breast Cancer Cell Line, Int J Cancer Manag. 2017 ;10(5):e5474. doi: 10.5812/ijcm.5474.
Copyright: Copyright © 2017, Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences. .
Abstract
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Qamri Z, Preet A, Nasser MW, Bass CE, Leone G, Barsky SH, et al. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer. Mol Cancer Ther. 2009; 8(11): 3117-29[DOI][PubMed]
  • 2. AbuHammad S, Zihlif M. Gene expression alterations in doxorubicin resistant MCF7 breast cancer cell line. Genomics. 2013; 101(4): 213-20[DOI][PubMed]
  • 3. Li BT, Wong MH, Pavlakis N. Treatment and Prevention of Bone Metastases from Breast Cancer: A Comprehensive Review of Evidence for Clinical Practice. J Clin Med. 2014; 3(1): 1-24[DOI][PubMed]
  • 4. Chakravarti B, Ravi J, Ganju RK. Cannabinoids as therapeutic agents in cancer: current status and future implications. Oncotarget. 2014; 5(15): 5852-72[DOI][PubMed]
  • 5. Wang K, Deng QT, Liao N, Zhang GC, Liu YH, Xu FP, et al. Tau expression correlated with breast cancer sensitivity to taxanes-based neoadjuvant chemotherapy. Tumour Biol. 2013; 34(1): 33-8[DOI][PubMed]
  • 6. Li ZH, Xiong QY, Tu JH, Gong Y, Qiu W, Zhang HQ, et al. Tau proteins expressions in advanced breast cancer and its significance in taxane-containing neoadjuvant chemotherapy. Med Oncol. 2013; 30(3): 591[DOI][PubMed]
  • 7. Lew GM. Tau protein after delta-9-tetrahydrocannabinol in a human neuroblastoma cell line. Gen Pharmacol. 1996; 27(7): 1141-3[PubMed]
  • 8. Matrone M, Whipple R, Balzer E, Cho E, Yoon J, Martin S. Metastasis-associated microtentacles are induced in detached and circulating breast tumor cells by expression of the microtubule-binding protein, Tau. Cancer Res. 2014; 69(2 Supplement): 55[DOI]
  • 9. Baquero MT, Lostritto K, Gustavson MD, Bassi KA, Appia F, Camp RL, et al. Evaluation of prognostic and predictive value of microtubule associated protein tau in two independent cohorts. Breast Cancer Res. 2011; 13(5)[DOI][PubMed]
  • 10. Mihaly Z, Kormos M, Lanczky A, Dank M, Budczies J, Szasz MA, et al. A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer. Breast Cancer Res Treat. 2013; 140(2): 219-32[DOI][PubMed]
  • 11. Rouzier R, Rajan R, Wagner P, Hess KR, Gold DL, Stec J, et al. Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer. Proc Natl Acad Sci U S A. 2005; 102(23): 8315-20[DOI][PubMed]
  • 12. Gavet O, Ozon S, Manceau V, Lawler S, Curmi P, Sobel A. The stathmin phosphoprotein family: intracellular localization and effects on the microtubule network. J Cell Sci. 1998; 111 ( Pt 22): 3333-46[PubMed]
  • 13. Bieche I, Maucuer A, Laurendeau I, Lachkar S, Spano AJ, Frankfurter A, et al. Expression of stathmin family genes in human tissues: non-neural-restricted expression for SCLIP. Genomics. 2003; 81(4): 400-10[PubMed]
  • 14. Nie W, Xu MD, Gan L, Huang H, Xiu Q, Li B. Overexpression of stathmin 1 is a poor prognostic biomarker in non-small cell lung cancer. Lab Invest. 2015; 95(1): 56-64[DOI][PubMed]
  • 15. Adams IB, Martin BR. Cannabis: pharmacology and toxicology in animals and humans. Addiction. 1996; 91(11): 1585-614[PubMed]
  • 16. Russo EB. Cannabis and cannabinoids: pharmacology, toxicology, and therapeutic potential. 2013;
  • 17. Guzman M. Cannabinoids: potential anticancer agents. Nat Rev Cancer. 2003; 3(10): 745-55[DOI][PubMed]
  • 18. Caffarel MM, Andradas C, Mira E, Perez-Gomez E, Cerutti C, Moreno-Bueno G, et al. Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition. Mol Cancer. 2010; 9: 196[DOI][PubMed]
  • 19. Fogli S, Breschi MC. The molecular bases of cannabinoid action in cancer. Cancer Ther. 2008; 6: 103-16
  • 20. Pisanti S, Malfitano AM, Grimaldi C, Santoro A, Gazzerro P, Laezza C, et al. Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents. Best Pract Res Clin Endocrinol Metab. 2009; 23(1): 117-31[DOI][PubMed]
  • 21. Matrone MA, Whipple RA, Thompson K, Cho EH, Vitolo MI, Balzer EM, et al. Metastatic breast tumors express increased tau, which promotes microtentacle formation and the reattachment of detached breast tumor cells. Oncogene. 2010; 29(22): 3217-27[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

International Journal of Cancer Management accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check